Ming Xu

机构：Shanxi Medical University, Wuhan University, Zhongnan Hospital of Wuhan University, First Hospital of Shanxi Medical University · ORCID：0000-0002-9353-759X

发表论文 51 篇 · 总被引 1175 次 · h-index 21

代表论文

• Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway (2019 · Anti-Cancer Drugs · 被引 62)
• Ezrin promotes breast cancer progression by modulating AKT signals (2019 · British Journal of Cancer · 被引 60)
• Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO (2020 · Aging · 被引 50)
• Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma (2019 · Gene · 被引 38)
• FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53 (2019 · Carcinogenesis · 被引 29)
• Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway (2021 · Aging · 被引 25)